AZVUDINE placebo

DRUG2 trials

Sponsors

HRH Pharmaceuticals Limited

Conditions

COVID-19

Phase 3

Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)

CompletedNCT04668235

HRH Pharmaceuticals LimitedCOVID-19

Start: 2021-04-23End: 2022-08-10Updated: 2022-08-12

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

CompletedNCT05033145

HRH Pharmaceuticals LimitedCOVID-19

Start: 2022-01-15End: 2022-07-27Updated: 2022-08-12

Related Papers

Phase III, randomized, double-blind, placebo-controlled clinical study: a study on the safety and clinical efficacy of AZVUDINE in moderate COVID-19 patients

Frontiers in Medicine2023-10-1927 citations

Serial viral load analysis by DDPCR to evaluate FNC efficacy and safety in the treatment of mild cases of COVID-19

Frontiers in Medicine2023-03-1441 citations

4′-Modified Nucleosides for Antiviral Drug Discovery: Achievements and Perspectives

Accounts of Chemical Research2022-01-2568 citations